Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic

Philip M Hansbro1, Matthew J Hamilton2, Michael Fricker1

  • 1From the Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Newcastle, New South Wales 2308, Australia.

Insights

Protease serine member S31 (Prss31) is a mast cell protease with dual roles. Deleting Prss31 reduced inflammation in lung and gut diseases but increased airway reactivity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pulmonary Medicine

Background:

  • Protease serine member S31 (Prss31), also known as transmembrane tryptase or tryptase-γ, is a mast cell-restricted protease.
  • Its function and role in mast cell activation and inflammatory diseases remain largely unknown.

Purpose of the Study:

  • To investigate the in vivo function of Prss31 by generating and characterizing Prss31-null mice.
  • To determine the role of Prss31 in mast cell activation and its contribution to inflammatory conditions like chronic obstructive pulmonary disease (COPD) and colitis.

Main Methods:

  • Generation of a novel Prss31-null mouse line using Cre/loxP homologous recombination.
  • Assessment of mast cell number, degranulation patterns, and protease expression in Prss31-null mice.
  • Evaluation of Prss31-null mice in cigarette smoke-induced COPD and dextran sodium sulfate-induced colitis models.

Main Results:

  • Prss31-null mice showed no developmental abnormalities or compensatory increases in other protease expression.
  • Activated Prss31-null mast cells degranulated similarly to wild-type mast cells.
  • Prss31-null mice exhibited increased baseline airway reactivity but reduced severity in experimental COPD and colitis models.
  • Specifically, Prss31-null mice had less pulmonary inflammation and fibrosis in COPD models and reduced colonic inflammation in colitis models compared to wild-type mice.

Conclusions:

  • Prss31 plays a complex role, contributing to airway hyperreactivity while suppressing inflammatory responses in the lung and gut.
  • Inhibiting membrane-bound Prss31 may offer therapeutic potential for mast cell-dependent inflammatory diseases such as COPD and colitis.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
35
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K